Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe new screenshot shows version updates including recruitment status and changes to contacts/locations, whereas the old screenshot did not reflect those latest updates. These version-level changes indicate ongoing updates to the trial record.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference9%

- Check49 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision updated to v3.0.2; 'Back to Top' link removed.SummaryDifference0.5%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.5%

- Check78 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference61%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.